Similar articles

• Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.

  Toda F, Tanabe K, Tokumoto T, Ishikawa N, Koga S, Ito S, Yagisawa T, Toma H. Toda F, et al. Transplant Proc. 2000 Nov;32(7):1726-9. doi: 10.1016/s0041-1345(00)01398-1. Transplant Proc. 2000. PMID: 11119909 Clinical Trial. No abstract available.
• Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.

  Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang JD, Okuyama A. Kokado Y, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):1151-4. doi: 10.1016/s0041-1345(98)01942-3. Transplant Proc. 1999. PMID: 10083515 No abstract available.
• Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.

  Kinukawa T, Ohshima S, Ono Y, Fujita T, Hattori R, Tanaka K. Kinukawa T, et al. Transplant Proc. 1998 Jun;30(4):1227-9. doi: 10.1016/s0041-1345(98)00220-6. Transplant Proc. 1998. PMID: 9636498 Clinical Trial. No abstract available.
• Tacrolimus (FK 506) in kidney transplantation.

  Vanrenterghem Y. Vanrenterghem Y. Transplant Proc. 1998 Aug;30(5):2171-3. doi: 10.1016/s0041-1345(98)00578-8. Transplant Proc. 1998. PMID: 9723431 Review. No abstract available.
• Withdrawal of steroids from a cyclosporine-based regimen: pro.

  Ponticelli C. Ponticelli C. Transplant Proc. 1998 Aug;30(5):1782-4. doi: 10.1016/s0041-1345(98)00430-8. Transplant Proc. 1998. PMID: 9723281 Review. No abstract available.